pharma · Gout · Asthma
Sunshine Guojian Pharmaceutical
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Sunshine Guojian Pharmaceutical is a pharma organization headquartered in FORT LAUDERDALE, FL, CN. Primary therapeutic focus areas include Gout, Asthma, Type 2 Diabetes, Dermatitis, Atopic, Chronic Hepatitis C. NovaPharm
FORT LAUDERDALE, FL, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- FORT LAUDERDALE, FL, CN
- Programs
- 165
- Drugs
- 80
- Patents
- 121
HEC585 dose A
Phase 2 · small molecule · Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
HEC585 dose A for Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF) is a Phase 2 program (small_molecule) at Sunshine Guojian Pharmaceutical (Shanghai) Co., with 1 ClinicalTrials.gov record(s).
Internal code HEC585-PF-202
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co.,
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
- Status
- active
- Trials
- 1